🎉 Another Major Milestone for HCmed! 🎉

We are thrilled to announce that AdheResp® has officially received TFDA clearance! 💨🙌🙌

This achievement marks another pivotal step forward in our global regulatory strategy, further solidifying our position as a trusted partner in the drug-device combination product market.

As our advanced breath-actuated mesh nebulizer platform with built-in connectivity gains broader regulatory validation, we are ready to accelerate your combination product development across key global regions.

Even better—this validated, customizable design is available at commercial scale, backed by our newly expanded manufacturing capacity to ensure a robust, high-quality supply chain for our partners.

This incredible milestone represents another significant step forward for HCmed, while highlighting our unwavering commitment to regulatory compliance, operational excellence, and to expanding the reach of innovative inhalation therapies worldwide.

“ Smarter care, broader horizons—and we are just getting started. “🙌